$0.3750
0.008902.43%
At close: -
$0.3801
0.005101.36%
After Hours: Jan 29, 7:32 PM EDT
Spruce Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Spruce Biosciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-11 | $-0.21 | $-0.24 | 12.5 % |
Q2 | 2024-08-12 | $-0.22 | $-0.30 | 26.7 % |
Q1 | 2024-05-13 | $-0.28 | $-0.29 | 3.45 % |
Q4 | 2024-03-13 | $-0.23 | $-0.39 | 41.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-11 | $602.00K | $1.49M | -59.6 % |
Q2 | 2024-08-12 | $1.61M | $1.50M | 7.69 % |
Q1 | 2024-05-13 | $2.02M | $1.16M | 74.1 % |
Q4 | 2024-03-13 | $2.89M | $1.40M | 106.2 % |
Spruce Biosciences (SPRB) is scheduled to report earnings on March 12, 2025. The last reported earnings were for reported on November 11, 2024 for Q3.
The Actual EPS was $-0.21, which beat the estimate of $-0.24.
The Actual Revenue was $602K, which missed the estimate of $1.5M.
Browse earnings estimates, EPS, and revenue on all stocks.